UPSC MainsMEDICAL-SCIENCE-PAPER-I201320 Marks
हिंदी में पढ़ें
Q33.

What are the possible contributing factors in pathogenesis of carcinoma breast ? Describe briefly histopathology of different types of breast carcinoma.

How to Approach

This question requires a two-pronged approach. First, detail the multifactorial pathogenesis of breast carcinoma, covering genetic, hormonal, and lifestyle factors. Second, provide a concise yet comprehensive description of the histopathology of common breast carcinoma types – ductal, lobular, inflammatory, and medullary. Structure the answer by first addressing pathogenesis, then systematically describing each carcinoma type with key histological features. Use bullet points and tables for clarity.

Model Answer

0 min read

Introduction

Breast carcinoma is the most frequently diagnosed cancer and the leading cause of cancer death among women worldwide. Its development is a complex, multi-step process influenced by a confluence of genetic predisposition, hormonal factors, and environmental influences. Understanding the pathogenesis is crucial for risk assessment and preventative strategies. Histopathological classification is essential for accurate diagnosis, prognosis, and treatment planning. This answer will explore the contributing factors to breast cancer development and briefly describe the histopathology of different types of breast carcinoma.

Pathogenesis of Carcinoma Breast

The pathogenesis of breast carcinoma is multifactorial, involving interactions between genetic, hormonal, and environmental factors. These factors contribute to the initiation, promotion, and progression of the disease.

  • Genetic Factors: Approximately 5-10% of breast cancers are linked to inherited gene mutations, most notably in BRCA1 and BRCA2 genes. Mutations in other genes like TP53, PTEN, and ATM also increase risk.
  • Hormonal Factors: Prolonged exposure to estrogen is a significant risk factor. Early menarche, late menopause, nulliparity (never having given birth), and hormone replacement therapy (HRT) increase estrogen exposure.
  • Reproductive History: Age at first full-term pregnancy (older age increases risk), number of pregnancies (more pregnancies generally decrease risk), and breastfeeding duration (longer duration decreases risk) all play a role.
  • Lifestyle Factors: Obesity, lack of physical activity, alcohol consumption, and smoking are associated with increased risk.
  • Environmental Factors: Exposure to ionizing radiation, particularly during adolescence, can increase risk.
  • Inflammation: Chronic inflammation in the breast tissue can contribute to cancer development.

Histopathology of Different Types of Breast Carcinoma

1. Invasive Ductal Carcinoma (IDC) – No Special Type (NST)

This is the most common type (70-80% of cases). Histologically, it’s characterized by:

  • Tumor cells infiltrating the breast ducts and surrounding stroma.
  • Variable differentiation – from well-differentiated (resembling normal ducts) to poorly differentiated (lacking ductal features).
  • Formation of nests, cords, or sheets of malignant cells.
  • Desmoplastic reaction – dense, fibrous stroma surrounding the tumor cells.

2. Invasive Lobular Carcinoma (ILC)

Represents 10-15% of cases. Key histological features include:

  • Tumor cells infiltrating the breast lobules and surrounding stroma in a single-file pattern (“Indian file” arrangement).
  • Loss of E-cadherin expression, a cell adhesion molecule, contributing to the infiltrative pattern.
  • Cells are often small, round, and lack prominent nucleoli.
  • Often presents as a diffuse thickening rather than a distinct mass.

3. Inflammatory Breast Carcinoma (IBC)

A rare but aggressive form (1-5% of cases). Histological features include:

  • Tumor cells blocking dermal lymphatic vessels, leading to skin edema and erythema (redness).
  • Often lacks a palpable mass.
  • Dermal lymphatic invasion by tumor cells is a hallmark feature.
  • Frequently associated with poor prognosis.

4. Medullary Carcinoma

Represents approximately 3-5% of cases. Histological features include:

  • Well-circumscribed, soft, and fleshy tumor.
  • Large, atypical cells with prominent nucleoli and abundant cytoplasm.
  • Heavy lymphocytic infiltrate surrounding the tumor cells.
  • Often associated with a better prognosis compared to other invasive ductal carcinomas.

5. Mucinous Carcinoma

Represents approximately 1-2% of cases. Histological features include:

  • Tumor cells floating in abundant extracellular mucin.
  • Cells are typically well-differentiated.
  • Often presents as a well-defined mass.
  • Generally has a favorable prognosis.
Carcinoma Type Key Histological Features Frequency (%)
Invasive Ductal Carcinoma (NST) Infiltration, variable differentiation, desmoplastic reaction 70-80
Invasive Lobular Carcinoma “Indian file” pattern, E-cadherin loss 10-15
Inflammatory Breast Carcinoma Dermal lymphatic invasion, skin edema 1-5
Medullary Carcinoma Well-circumscribed, lymphocytic infiltrate 3-5

Conclusion

Carcinoma breast is a heterogeneous disease with a complex pathogenesis involving genetic, hormonal, and lifestyle factors. Accurate histopathological classification is paramount for guiding treatment strategies and predicting prognosis. Continued research into the molecular mechanisms driving breast cancer development is crucial for improving prevention, early detection, and therapeutic interventions. Understanding the nuances of each subtype allows for personalized medicine approaches, ultimately improving patient outcomes.

Answer Length

This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.

Additional Resources

Key Definitions

Estrogen Receptor (ER)
A protein found inside breast cancer cells that binds to estrogen, promoting cell growth. ER-positive cancers are more likely to respond to hormone therapy.
In Situ Carcinoma
Cancer cells are present only in their original location (e.g., ducts or lobules) and have not invaded surrounding tissues. Ductal Carcinoma In Situ (DCIS) and Lobular Carcinoma In Situ (LCIS) are examples.

Key Statistics

In 2020, there were 2.3 million new cases of breast cancer diagnosed worldwide.

Source: World Health Organization (WHO), 2020

Approximately 1 in 8 women in the United States will develop invasive breast cancer over the course of their lifetime.

Source: American Cancer Society, 2023 (knowledge cutoff)

Examples

Angelina Jolie's Prophylactic Mastectomy

Angelina Jolie underwent prophylactic bilateral mastectomy and oophorectomy in 2013 after discovering she carried a BRCA1 gene mutation, significantly reducing her risk of developing breast and ovarian cancer.

Frequently Asked Questions

What is the role of HER2 in breast cancer?

HER2 (Human Epidermal growth factor Receptor 2) is a protein that promotes cancer cell growth. HER2-positive breast cancers are more aggressive but can be treated with targeted therapies like trastuzumab.

Topics Covered

PathologyOncologyBreast CancerPathogenesisHistopathology